Processing and regulation mechanisms within antigen presenting cells

a possibility for therapeutic modulation

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Processing of antigens within antigen presenting cells (APCs) is necessary for an immune response. Two pathways exist to present antigens to T cells: the major histocompatibility complex class I (MHC I) pathway to activate cytotoxic T cells (CTLs) and the MHC II route to stimulate T helper cells (Ths). Prior to efficient antigen presentation to MHC II, antigens have to be proteolytically degraded by proteases, the cathepsins, inside the endocytic compartment of APCs. Cathepsins process both antigens and self-antigens to antigenic peptides; the latter are critical for autoimmunity. Remarkably, distribution, substrate specificity, and function of cathepsins located in the antigen processing machinery depend on the cell type, primary or cultured cells, or species analyzed. However, a precise understanding of the antigen processing and presentation machinery is needed to generate specific immune modulators since the MHC antigen- processing pathway is subsequently regulated during tumorigenesis, infection, or autoimmunity. In this review, the latest finding regarding function and regulation of the MHC II proteolytic machinery and its possible target for immunomodulation will be discussed.

Original languageEnglish
Pages (from-to)1029-42
Number of pages14
JournalCurrent Pharmaceutical Design
Volume19
Issue number6
Publication statusPublished - 2013
Externally publishedYes

Fingerprint

Antigen Presentation
Antigen-Presenting Cells
Cathepsins
Autoimmunity
Antigens
Therapeutics
T-Lymphocytes
Immunomodulation
Autoantigens
Substrate Specificity
Helper-Inducer T-Lymphocytes
Major Histocompatibility Complex
Cultured Cells
Carcinogenesis
Peptide Hydrolases
Peptides
Infection

Keywords

  • Animals
  • Antigen-Presenting Cells
  • Autoimmunity
  • Humans
  • Neoplasms
  • T-Lymphocytes, Cytotoxic
  • Journal Article
  • Review

Cite this

Processing and regulation mechanisms within antigen presenting cells : a possibility for therapeutic modulation. / Burster, Timo.

In: Current Pharmaceutical Design, Vol. 19, No. 6, 2013, p. 1029-42.

Research output: Contribution to journalReview article

@article{5fddff60008741bc833575a19b00c215,
title = "Processing and regulation mechanisms within antigen presenting cells: a possibility for therapeutic modulation",
abstract = "Processing of antigens within antigen presenting cells (APCs) is necessary for an immune response. Two pathways exist to present antigens to T cells: the major histocompatibility complex class I (MHC I) pathway to activate cytotoxic T cells (CTLs) and the MHC II route to stimulate T helper cells (Ths). Prior to efficient antigen presentation to MHC II, antigens have to be proteolytically degraded by proteases, the cathepsins, inside the endocytic compartment of APCs. Cathepsins process both antigens and self-antigens to antigenic peptides; the latter are critical for autoimmunity. Remarkably, distribution, substrate specificity, and function of cathepsins located in the antigen processing machinery depend on the cell type, primary or cultured cells, or species analyzed. However, a precise understanding of the antigen processing and presentation machinery is needed to generate specific immune modulators since the MHC antigen- processing pathway is subsequently regulated during tumorigenesis, infection, or autoimmunity. In this review, the latest finding regarding function and regulation of the MHC II proteolytic machinery and its possible target for immunomodulation will be discussed.",
keywords = "Animals, Antigen-Presenting Cells, Autoimmunity, Humans, Neoplasms, T-Lymphocytes, Cytotoxic, Journal Article, Review",
author = "Timo Burster",
year = "2013",
language = "English",
volume = "19",
pages = "1029--42",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers",
number = "6",

}

TY - JOUR

T1 - Processing and regulation mechanisms within antigen presenting cells

T2 - a possibility for therapeutic modulation

AU - Burster, Timo

PY - 2013

Y1 - 2013

N2 - Processing of antigens within antigen presenting cells (APCs) is necessary for an immune response. Two pathways exist to present antigens to T cells: the major histocompatibility complex class I (MHC I) pathway to activate cytotoxic T cells (CTLs) and the MHC II route to stimulate T helper cells (Ths). Prior to efficient antigen presentation to MHC II, antigens have to be proteolytically degraded by proteases, the cathepsins, inside the endocytic compartment of APCs. Cathepsins process both antigens and self-antigens to antigenic peptides; the latter are critical for autoimmunity. Remarkably, distribution, substrate specificity, and function of cathepsins located in the antigen processing machinery depend on the cell type, primary or cultured cells, or species analyzed. However, a precise understanding of the antigen processing and presentation machinery is needed to generate specific immune modulators since the MHC antigen- processing pathway is subsequently regulated during tumorigenesis, infection, or autoimmunity. In this review, the latest finding regarding function and regulation of the MHC II proteolytic machinery and its possible target for immunomodulation will be discussed.

AB - Processing of antigens within antigen presenting cells (APCs) is necessary for an immune response. Two pathways exist to present antigens to T cells: the major histocompatibility complex class I (MHC I) pathway to activate cytotoxic T cells (CTLs) and the MHC II route to stimulate T helper cells (Ths). Prior to efficient antigen presentation to MHC II, antigens have to be proteolytically degraded by proteases, the cathepsins, inside the endocytic compartment of APCs. Cathepsins process both antigens and self-antigens to antigenic peptides; the latter are critical for autoimmunity. Remarkably, distribution, substrate specificity, and function of cathepsins located in the antigen processing machinery depend on the cell type, primary or cultured cells, or species analyzed. However, a precise understanding of the antigen processing and presentation machinery is needed to generate specific immune modulators since the MHC antigen- processing pathway is subsequently regulated during tumorigenesis, infection, or autoimmunity. In this review, the latest finding regarding function and regulation of the MHC II proteolytic machinery and its possible target for immunomodulation will be discussed.

KW - Animals

KW - Antigen-Presenting Cells

KW - Autoimmunity

KW - Humans

KW - Neoplasms

KW - T-Lymphocytes, Cytotoxic

KW - Journal Article

KW - Review

M3 - Review article

VL - 19

SP - 1029

EP - 1042

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 6

ER -